Vesilute Peptide 20mg

Description

What Is Vesilute Peptide?

Vesilute peptide is a synthetic tripeptide bioregulator with the amino acid sequence Lys-Glu-Asp (KED), developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Vesilute belongs to the Khavinson bioregulator peptides class — short control peptides that tune tissue-specific gene expression at natural levels. Vesilute’s main research targets are the urinary bladder wall and vascular endothelium, though it has also been studied for broader brain-safe and anti-aging properties in lab gerontology models due to its effects on vascular smooth muscle and endothelial gene expression.

As a bladder bioregulator with vascular and brain-safe research uses, vesilute operates through the Khavinson epigenetic mechanism — interacting with paired DNA sequences in gene promoter regions to tune transcription of tissue-specific genes involved in smooth muscle contractility, endothelial function, and age-related vascular decline. PrymaLab Vesilute 20mg is manufactured to high purity standards and supplied exclusively for qualified lab research.

Vesilute 20mg: Key Specifications

How Vesilute Works: Bioregulator Mechanism of Action

Vesilute operates through the Khavinson model of peptide bioregulation, tuning gene expression through direct peptide-DNA interaction in promoter regions of target genes. The KED tripeptide sequence has showed affinity for DNA motifs enriched in genes governing smooth muscle contractility, endothelial nitric oxide control, and vascular wall homeostasis.

Vascular Endothelial Gene Modulation

Vesilute has been studied for its effects on endothelial cell gene expression, including genes regulating nitric oxide synthase (eNOS) activity, prostacyclin production, and vascular smooth muscle tone. In aged vascular tissue models, vesilute use was linked with restoration of endothelial gene expression profiles that deteriorate with vascular aging — a process central to age-related heart and cerebrovascular decline. This vascular mechanism underlies vesilute’s emerging research interest as a brain-safe agent, since cerebral vascular health is a main determinant of neuronal survival and cognitive function during aging.

Bladder Smooth Muscle Function

The urinary bladder detrusor muscle is a highly specialized smooth muscle tissue whose contractile capacity and neural coordination decline progressively with aging. Vesilute has been studied in bladder tissue models for its effects on smooth muscle contractility gene expression, detrusor muscle functional markers, and the balance between muscarinic receptor signaling and beta-adrenergic relaxation pathways that govern bladder filling and voiding reflexes.

Neuroprotective and Anti-aging Properties

Vesilute’s vascular endothelial effects extend to brain safety through the cerebrovascular pathway. Age-related decline in cerebral blood vessel function reduces nutrient and oxygen supply to neurons, adding to cognitive decline and neurodegeneration. By tuning endothelial gene expression and supporting vascular tone control, vesilute has been studied in research models examining whether vascular bioregulation can provide indirect brain-safe effects in aging brain tissue — a research paradigm increasingly recognized as key to grasp age-related cognitive decline.

Vesilute Peptide Benefits: What Research Shows

The following reflects published lab and gerontological literature. PrymaLab Vesilute 20mg is supplied exclusively for research purposes.

Vascular Function Restoration in Aging Models

Research from the Khavinson group reports that vesilute use in aged animal models was linked with improved endothelial function markers, including enhanced nitric oxide-dependent vasodilation, reduced endothelial dysfunction indices, and normalization of vascular smooth muscle tone. These effects are attributed to restoration of endothelial gene expression patterns toward younger functional profiles.

Bladder Function Support

Lab studies have documented vesilute’s effects on age-related bladder dysfunction markers, including improved detrusor muscle contractility parameters, normalized voiding reflex indicators, and maintenance of bladder wall structural integrity in aged tissue models. These findings position vesilute as a unique bioregulator targeting an organ system — the urinary bladder — that greatly impacts quality of life during aging but gets limited research attention compared to heart or neurological systems.

Cerebrovascular and Neuroprotective Effects

Emerging research interest in vesilute centers on its indirect brain-safe effects mediated through cerebrovascular health. Published data from gerontological models shows improved cerebral blood flow parameters and reduced markers of vascular-mediated neuronal stress in aged animals treated with vascular bioregulator peptides. This cerebrovascular brain safety mechanism is distinct from direct neuronal bioregulators like cortagen, making vesilute relevant to paired multi-organ bioregulation research protocols.

Vesilute vs. Cardiogen: Vascular Bioregulator Comparison

How to Store and Handle PrymaLab Vesilute 20mg

1. Store freeze-dried at −20°C. Keep sealed, desiccated, and protected from light. Stable for 24+ months.
2. Allow vial to reach room heat before opening to prevent condensation.
3. Reconstitute with appropriate sterile solvent (sterile water or sterile saline). Add slowly along vial wall.
4. Use mixed solution within 2–4 weeks. Refrigerate at 2–8°C and mark date.
5. Avoid repeated freeze-thaw cycles. Aliquot into single-use portions if needed.
6. Retain the Certificate of Test for lot traceability and records.

Why Choose PrymaLab Vesilute 20mg?

PrymaLab supplies Vesilute 20mg as a high-purity research-grade bioregulator peptide verified at ≥98% purity by reverse-phase HPLC and identity-confirmed by mass spectrometry. Each batch ships with a unique lot number and Certificate of Test. Independent third-party testing ensures unbiased quality check and full traceability for GLP-compliant research environments.

Frequently Asked Questions About Vesilute Peptide

What is vesilute peptide and what does it target?

Vesilute is a synthetic tripeptide bioregulator (Lys-Glu-Asp, KED) developed by Professor Khavinson that targets the bladder wall, vascular endothelium, and smooth muscle tissue. It belongs to the Khavinson bioregulator peptide class and has been studied for vascular function restoration, bladder support, and indirect brain-safe effects via cerebrovascular health in lab aging research models.

How does vesilute provide neuroprotective effects?

Vesilute’s brain-safe properties are mediated through its vascular endothelial effects rather than direct neuronal action. By restoring endothelial gene expression and supporting cerebrovascular function — including nitric oxide-dependent vasodilation and cerebral blood flow control — vesilute helps keep the vascular supply of oxygen and nutrients to brain tissue that declines during aging. This vascular brain safety mechanism is paired to direct neuronal bioregulators like cortagen.

What is the difference between vesilute and cardiogen?

Both target the heart system but through different tissue types. Vesilute (KED) focuses on vascular endothelium and smooth muscle, supporting blood vessel function and bladder wall integrity. Cardiogen (AEDR) targets cardiac muscle (cardiomyocytes), focusing on heart tissue gene expression and cardiac function. Research protocols sometimes combine both for full heart system support.

How should vesilute be stored?

Store freeze-dried vesilute at −20°C, desiccated and protected from light, for 24+ months shelf life. After mixing, refrigerate at 2–8°C and use within 2–4 weeks. Avoid repeated freeze-thaw cycles.

What purity does PrymaLab vesilute achieve?

PrymaLab Vesilute 20mg is verified at ≥98% purity by reverse-phase HPLC and identity-confirmed by mass spectrometry. Each batch includes a Certificate of Test with independent third-party testing results for unbiased quality check.

Research Disclaimer

For Research Use Only. PrymaLab Vesilute 20mg is intended exclusively for qualified lab research use. This product is not intended for human consumption, treatment use, veterinary treatment, or any use outside controlled research environments. Vesilute has not been approved by the FDA or any equivalent control authority for treatment use. All research uses described are from published lab and gerontological literature. Researchers are responsible for control compliance.